Melanotan II

Drug Profile

Melanotan II

Alternative Names: MT II; PT-14

Latest Information Update: 22 Sep 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator University of Arizona
  • Class Erectile dysfunction therapies; Peptide hormones
  • Mechanism of Action Melanocortin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Erectile dysfunction; Male sexual dysfunction

Most Recent Events

  • 22 Sep 2003 Discontinued - Phase-II for Erectile dysfunction in USA (Injection)
  • 22 Sep 2003 Discontinued - Phase-II for Male sexual dysfunction in USA (Injection)
  • 08 Mar 2002 Discontinued - Preclinical for Erectile dysfunction in USA (Transmucosal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top